Oscar Health, Inc. (NYSE:OSCR) Given Consensus Rating of "Reduce" by Brokerages

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) has received a consensus recommendation of "Reduce" from the seven brokerages that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $16.58.

A number of equities analysts recently issued reports on the company. Barclays assumed coverage on Oscar Health in a report on Wednesday. They issued an "underweight" rating and a $17.00 price target for the company. Wall Street Zen downgraded Oscar Health from a "buy" rating to a "hold" rating in a report on Sunday, June 8th. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price objective for the company from $20.00 to $16.00 in a research note on Thursday, March 13th. Piper Sandler reduced their price objective on Oscar Health from $25.00 to $18.00 and set an "overweight" rating for the company in a research note on Monday, June 9th. Finally, Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th.

Insider Activity at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the completion of the sale, the director owned 64,512 shares in the company, valued at $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 24.39% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

Several large investors have recently modified their holdings of the stock. Rhumbline Advisers raised its stake in shares of Oscar Health by 6.0% during the first quarter. Rhumbline Advisers now owns 287,458 shares of the company's stock worth $3,769,000 after purchasing an additional 16,231 shares during the last quarter. Strs Ohio purchased a new stake in shares of Oscar Health during the first quarter worth approximately $30,000. Intech Investment Management LLC raised its stake in shares of Oscar Health by 50.3% during the first quarter. Intech Investment Management LLC now owns 139,600 shares of the company's stock worth $1,830,000 after purchasing an additional 46,748 shares during the last quarter. Focus Partners Wealth raised its stake in shares of Oscar Health by 1.8% during the first quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after purchasing an additional 949 shares during the last quarter. Finally, SCS Capital Management LLC purchased a new stake in shares of Oscar Health during the first quarter worth approximately $131,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Stock Performance

Shares of OSCR opened at $16.52 on Friday. The stock has a 50 day moving average price of $16.02 and a 200 day moving average price of $14.81. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.22. The company has a market capitalization of $4.21 billion, a price-to-earnings ratio of 59.00 and a beta of 1.90. Oscar Health has a 52-week low of $11.20 and a 52-week high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm's quarterly revenue was up 42.2% compared to the same quarter last year. During the same period in the prior year, the company posted $0.62 earnings per share. Research analysts predict that Oscar Health will post 0.69 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.